VRTX · News · 20261103N

Net Income and Profitability

VERTEX PHARMACEUTICALS INC / MA · 2026-11-03 · Importance 31 · Surprise 14

Vertex reported third-quarter 2026 net income of $653.6 million, or $2.56 per share. Adjusted earnings were $4.76 per share, down 0.8% from $4.80 a year earlier and below the $4.92 Zacks consensus estimate. Higher operating expenses, higher interest costs, and lower interest income offset higher product revenue.

Key facts

• Vertex reported Q3 2026 profit of $653.6 million and net income of $2.56 per share; adjusted earnings were $4.76 per share. source
• Vertex's Q3 2026 adjusted earnings were $4.76 per share, missing the Zacks Consensus Estimate of $4.92; earnings declined 0.8% year over year as higher product revenues were offset by increased operating expenses, higher interest costs and lower interest income. source
• Vertex reported Q3 2026 non-GAAP earnings of $4.76 per share, 3.25% below the Zacks Consensus Estimate of $4.92 and down from $4.80 a year earlier. source
• Vertex's Q3 2026 adjusted earnings of $4.76 per share missed the Zacks estimate of $4.92. source
• Vertex's nine-month profit and per-share earnings were slightly higher than the prior period, while quarterly net income and earnings per share were lower. source